Levomilnacipran Hydrochloride

Levomilnacipran Hydrochloride (CAS No.: 175131-60-9) is a synthetic small molecule and the enantiomeric form of milnacipran hydrochloride that is broadly categorized as a monoamine transport modulator within neuropharmacology and central nervous system focused drug discovery research, with primary use as a reference compound for studying serotonin and norepinephrine reuptake processes, transporter selectivity, and blood brain barrier disposition including reported interaction with P glycoprotein mediated transport; mechanistically, it functions as a serotonin norepinephrine reuptake inhibitor acting on the norepinephrine transporter and serotonin transporter to elevate extracellular monoaminergic signaling and is therefore commonly applied to pathway level investigations of monoamine dependent stress response, affective behavior circuitry, and synaptic neurotransmitter homeostasis, while in vitro pharmacology indicates transporter inhibition in the nanomolar range and supports its utility in potency ranking, target engagement assays, and comparative profiling against related transporter ligands, and in experimental practice it is used in cell based uptake systems, transporter expressing recombinant models, and preclinical animal paradigms designed to interrogate central monoaminergic biology, with the concentrations or doses used in experiments typically depending on specific experimental designs and research objectives as well as assay platform, exposure duration, and endpoint sensitivity.